Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

264.85
Delayed Data
As of May 23
 +1.19 / +0.45%
Today’s Change
242.07
Today|||52-Week Range
420.99
-13.55%
Year-to-Date
Jeff Auxier's Spring 6 Market Commentary
May 20 / GuruFocus News - Paid Partner Content
Ionis Pharmaceuticals Inc Is Burning Partners' Cash (Thank Goodness There's Lots of I...
May 10 / MotleyFool.com - Paid Partner Content
Stock Market News for May 13, 2016
May 13 / Zacks.com - Paid Partner Content
Stock Market News for May 10, 2016
May 10 / Zacks.com - Paid Partner Content
Perrigo (PRGO) Tops Q1 Earnings, 2016 Earnings View Intact
May 12 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close263.66
Today’s open263.77
Day’s range263.15 - 267.18
Volume848,539
Average volume (3 months)1,810,402
Market cap$58.0B
Dividend yield--
Data as of 05/23/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+10.91%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)-3.87%
P/E ratio16.3
Price/Sales7.60
Price/Book6.18

Competitors

 Today’s
change
Today’s
% change
BXLTBaxalta Inc+0.18+0.41%
BAXBaxter International...-0.22-0.51%
GILDGilead Sciences+0.69+0.83%
JUNOJuno Therapeutics In...-0.57-1.40%
Data as of 05/23/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$4.67
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs